Oregon Health and Science University conducted a limited size clinical trial of QueaseEASE® testing efficacy and satisfaction. Findings showed 85% of users had total relief of nausea and were satisfied with QueaseEASE®
AUTHOR(S): Jennifer Francis, RN, Lynn Truscott, RN
DATE: April 2017
READ THE FULL STUDY BELOW:
CHH Short Stay recognized that PONV was a challenge with day stay patients. IV medication used to treat PONV is sedating, making it difficult to discharge patients.
ASPAN has recognized postoperative and post-discharge nausea and vomiting (PONV/PDNV) as one of the most commonly occurring postoperative complications, frequently resulting in prolonged postoperative stay, unanticipated admissions and increased health care costs.
CHH Short Stay conducted a small trial study with QueaseEASE®. We found 85% of patients were satisfied and had total relief of nausea. We plan to continue conducting an evidence-based nurse practice study to implement the use of QueaseEASE®. Data collection will be obtained through Epic and postoperative phone calls.